Provided by Tiger Trade Technology Pte. Ltd.

Atara Biotherapeutics

9.38
-0.5100-5.16%
Post-market: 9.380.00000.00%16:10 EDT
Volume:16.02K
Turnover:152.56K
Market Cap:94.15M
PE:-7.89
High:10.00
Open:10.00
Low:9.38
Close:9.89
52wk High:19.15
52wk Low:3.92
Shares:10.04M
Float Shares:4.62M
Volume Ratio:0.22
T/O Rate:0.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1889
EPS(LYR):2.57
ROE:-2014.86%
ROA:-24.14%
PB:-2.54
PE(LYR):3.65

Loading ...

Atara Biotherapeutics Raised to Buy From Hold by Canaccord Genuity

Dow Jones
·
May 09

Atara Biotherapeutics upgraded to Buy from Hold at Canaccord

TIPRANKS
·
May 08

Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA), Artivion (AORT) and Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
May 08

Atara Biotherapeutics jumps 70%, or $3.60, to $8.75

TIPRANKS
·
May 08

Atara Biotherapeutics trading resumes

TIPRANKS
·
May 08

BUZZ-U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise

Reuters
·
May 08

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:50 AM

Reuters
·
May 07

BUZZ-Atara jumps after US FDA backs re-submission of cancer drug application

Reuters
·
May 07

Atara Biotherapeutics Shares Jump 42% After US FDA Backs Resubmission of Co's Cancer Drug Application

THOMSON REUTERS
·
May 07

Atara Biotherapeutics Gains Clearer FDA Path for Tab-cel

TIPRANKS
·
May 07

Why Is Atara Biotherapeutics Stock (ATRA) Up Today?

TIPRANKS
·
May 07

BRIEF-Atara Biotherapeutics Provides Regulatory Update On Tabelecleucel

Reuters
·
May 07

Atara Biotherapeutics Inc - FDA Agrees Single Arm Study May Support Future Tab-Cel Marketing Application

THOMSON REUTERS
·
May 07

Atara Biotherapeutics Inc - Expects Further Tab-Cel Regulatory Update in Third Quarter

THOMSON REUTERS
·
May 07

Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel

THOMSON REUTERS
·
May 07

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 06

Atara Biotherapeutics Receives Nasdaq Non-Compliance Delisting Notice

TIPRANKS
·
May 02

Atara Biotherapeutics risks Nasdaq delisting after market value falls below $50 million threshold

Reuters
·
May 02

Atara Biotherapeutics announces annual shareholder meeting via virtual webcast

Reuters
·
Apr 25

Atara Biotherapeutics Faces Securities Lawsuit After FDA Setbacks and Sharp Stock Declines Tied to Tabelecleucel

TIPRANKS
·
Apr 17